3β-acetyl tormentic acid induces apoptosis of resistant leukemia cells independently of P-gp/ABCB1 activity or expression (Q39660008)

13 September 2017

3β-acetyl tormentic acid induces apoptosis of resistant leukemia cells independently of P-gp/ABCB1 activity or expression (English)

1 reference

13 September 2017

1 reference

Gleice da Graça Rocha

1

1 reference

13 September 2017

Marisol Simões

2

1 reference

13 September 2017

Rodrigo Rodrigues Oliveira

3

1 reference

13 September 2017

Maria Auxiliadora Coelho Kaplan

4

1 reference

13 September 2017

Cerli Rocha Gattass

5

1 reference

13 September 2017

4 September 2010

1 reference

Investigational New Drugs

13 September 2017

1 reference

13 September 2017

30

1 reference

13 September 2017

1

1 reference

13 September 2017

105-113

1 reference

https://scigraph.springernature.com/pub.10.1007/s10637-010-9524-1

13 September 2017

0 references

cites work

Changing picture of cellular drug resistance in human leukemia

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9524-1

Resistance mechanisms associated with altered intracellular distribution of anticancer agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9524-1

A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9524-1

ABC multidrug transporters: structure, function and role in chemoresistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9524-1

Quantitative molecular monitoring of BCR-ABL and MDR1 transcripts in patients with chronic myeloid leukemia during Imatinib treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9524-1

Important therapeutic targets in chronic myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9524-1

Chronic myeloid leukaemia as a model of disease evolution in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9524-1

State-of-the-art in the treatment of chronic myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9524-1

MDR1 gene overexpression confers resistance to imatinib mesylate in leukemia cell line models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9524-1

Activity of drugs from traditional Chinese medicine toward sensitive and MDR1- or MRP1-overexpressing multidrug-resistant human CCRF-CEM leukemia cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9524-1

Pentacyclic triterpenes from Chrysobalanaceae species: cytotoxicity on multidrug resistant and sensitive leukemia cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9524-1

Oleanolic acid inhibits the activity of the multidrug resistance protein ABCC1 (MRP1) but not of the ABCB1 (P-glycoprotein): possible use in cancer chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9524-1

Natural triterpenoids from Cecropia lyratiloba are cytotoxic to both sensitive and multidrug resistant leukemia cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9524-1

Multidrug resistance in tumour cells: characterization of the multidrug resistant cell line K562-Lucena 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9524-1

Valproic acid inhibits proliferation and induces apoptosis in acute myeloid leukemia cells expressing P-gp and MRP1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9524-1

A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9524-1

Use of fluorescent dyes as molecular probes for the study of multidrug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9524-1

The role of interferon-alpha in the treatment of chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9524-1

Molecular mechanisms of resistance to imatinib in Philadelphia-chromosome-positive leukaemias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9524-1

Nilotinib therapy in chronic myelogenous leukemia: the strength of high selectivity on BCR/ABL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9524-1

Nilotinib (AMN107, Tasigna) reverses multidrug resistance by inhibiting the activity of the ABCB1/Pgp and ABCG2/BCRP/MXR transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9524-1

Evidence that resistance to nilotinib may be due to BCR-ABL, Pgp, or Src kinase overexpression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9524-1

MDR1/P-glycoprotein (ABCB1) as target for RNA interference-mediated reversal of multidrug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9524-1

Recent advances on the molecular mechanisms involved in the drug resistance of cancer cells and novel targeting therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9524-1

Is resistance useless? Multidrug resistance and collateral sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9524-1

Pharmacological strategies for overcoming multidrug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9524-1

P-glycoprotein (P-170) expression in acute leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9524-1

The role of the mitochondria in mediating cytotoxicity of anti-cancer therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9524-1

MRP3, BCRP, and P-glycoprotein activities are prognostic factors in adult acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9524-1

Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia: a Southwest Oncology Group Study

21 January 2018

1 reference

12 December 2020

Reversal mechanism of multidrug resistance by verapamil: direct binding of verapamil to P-glycoprotein on specific sites and transport of verapamil outward across the plasma membrane of K562/ADM cells

1 reference

12 December 2020

Effects of selected flavonoids and carotenoids on drug accumulation and apoptosis induction in multidrug-resistant colon cancer cells expressing MDR1/LRP.

1 reference

12 December 2020

Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome

1 reference

12 December 2020

5-Bromotetrandrine enhances the sensitivity of doxorubicin-induced apoptosis in intrinsic resistant human hepatic cancer Bel7402 cells

1 reference

12 December 2020

Monitoring patients in complete cytogenetic remission after treatment of CML in chronic phase with imatinib: patterns of residual leukaemia and prognostic factors for cytogenetic relapse

1 reference

12 December 2020

Chronic myeloid leukemia in 2007.

1 reference

12 December 2020

Betulinic acid does not modulate the activity of P-gp/ABCB1 or MRP1/ABCC1 in a non-tumoral renal cell line: Possible utility in multidrug resistance cancer chemotherapy.

1 reference

12 December 2020

1 reference

12 December 2020

10.1007/S10637-010-9524-1

Identifiers

DOI

1 reference

13 September 2017

1 reference